Patent · US Active

Composition for topical use

US9463182B2 · kind B2 · utility

0Cited by
2References
7Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 7, 2014
Grant dateOct 11, 2016
Priority date
Expiry dateNov 7, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The use, as a dermatological or cosmetic ingredient, of compounds capable of transiently interacting with the AhR receptor (aryl hydrocarbon receptor) as agents for modulating skin functions such as sebaceous function, skin healing, skin atrophy termed “dermatoporosis”, estrogen deprivation and defense against infection, without inducing other toxic effects of the TCDD type. The compounds that interact the AhR receptor are chosen in that they have a metabolism favorable to the dissociation of these effects, in particular by virtue of in situ production from a precursor and/or metabolization in situ.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.